Toronto Dominion Bank Horizon Therapeutics Public LTD CO Transaction History

Toronto Dominion Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 14, 2024	SELL	$98.98 - $115.74 $34.4 Million - $40.2 Million	-347,520 Reduced 49.1%	360,236 $41.7 Million
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $34.4 Million - $40.2 Million	-347,520 Reduced 49.1%	360,236 $41.7 Million
Q2 2023 Feb 14, 2024	BUY	$96.34 - $112.38 $68.2 Million - $79.5 Million	707,756 New	707,756 $72.7 Million
Q2 2023 Aug 10, 2023	BUY	$96.34 - $112.38 $50.3 Million - $58.7 Million	522,420 Added 281.88%	707,756 $72.7 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $19.9 Million - $21 Million	185,145 Added 96934.55%	185,336 $20.2 Million
Q4 2022 Feb 07, 2023	SELL	$62.39 - $113.8 $3,868 - $7,055	-62 Reduced 24.51%	191 $22,000
Q3 2022 Nov 09, 2022	BUY	$58.92 - $84.67 $14,906 - $21,421	253 New	253 $16,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.